Risk factors for treatment failure in scabies: a cohort study

被引:31
|
作者
Aussy, A. [1 ,2 ]
Houivet, E. [3 ,4 ]
Hebert, V. [1 ,2 ]
Colas-Cailleux, H. [1 ,2 ]
Laaengh, N. [1 ,2 ]
Richard, C. [1 ,2 ]
Ouvry, M. [1 ,2 ]
Boulard, C. [1 ,2 ]
Leger, S. [1 ,2 ]
Litrowski, N. [1 ,2 ]
Benichou, J. [3 ,4 ]
Joly, P. [1 ,2 ]
Bechu, S.
Mion-Mouton, N.
Lafaurie, O.
Barrel, A.
Pulluard, M.
Hamel, V.
Dore, M. X.
Duflo, E.
Lardans-Cassius, S.
Rzeznik, J. C.
Baricault, S.
机构
[1] Rouen Univ Hosp, Dept Dermatol, Rouen, France
[2] Univ Rouen Normandie, INSERM, U1234, Rouen, France
[3] Rouen Univ Hosp, Dept Biostat, Rouen, France
[4] Univ Rouen Normandie, INSERM, U1219, Rouen, France
关键词
ORAL IVERMECTIN; PREVALENCE; EPIDEMIOLOGY; CREAM;
D O I
10.1111/bjd.17348
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Treatment failure, which occurs in about one-third of cases, is considered as a major factor in the increasing incidence of scabies in developed countries. Objectives To identify predictors of treatment failure of scabies in ambulatory populations. Methods This multicentre study compared the clinical characteristics and treatment modalities between a group of patients with scabies treated successfully and another group who were not cured 3 months after antiscabies treatment. Results In total 210 patients with a diagnosis of scabies were included, comprising 98 patients in the treatment success group and 112 in the treatment failure group. The main risk factors for treatment failure were (i) the use of only one type of treatment, topical benzyl benzoate (BB) or oral ivermectin, vs. the combination of both treatments [odds ratio (OR) 2 center dot 15, 95% confidence interval (CI) 1 center dot 22-3 center dot 77]; (ii) the use of a single intake (vs. two) of oral ivermectin (OR 10 center dot 2. 95% CI 4 center dot 49-23 center dot 2); (iii) intake of ivermectin during a meal vs. on an empty stomach (OR 4 center dot 31, 95% CI 1 center dot 89-9 center dot 84); (iv) absence of decontamination of furnishings (OR 8 center dot 72, 95% CI 3 center dot 50-21 center dot 8), in particular sofa and cushions (OR 5 center dot 90, 95% CI 2 center dot 34-14 center dot 9), mattresses (OR 4 center dot 16, 95% CI 1 center dot 35-12 center dot 8) or car seats (OR 6 center dot 57, 95% CI 3 center dot 27-13 center dot 2) and (v) absence of written documents explaining treatment modalities (OR 5 center dot 18, 95% CI 2 center dot 57-10 center dot 4). In multivariate analysis, treatment failure was mainly associated with (i) use of a single intake (vs. two) of ivermectin (OR 6 center dot 62, 95% CI 2 center dot 71-16 center dot 2); (ii) use of BB alone vs. two intakes of ivermectin (OR 3 center dot 51, 95% CI 1 center dot 55-7 center dot 95) and (iii) absence of decontamination of furniture with acaricides (OR 5 center dot 81, 95% CI 1 center dot 96-16 center dot 7). Conclusions Use of topical BB alone and a single intake (vs. two) of ivermectin are predictors of treatment failure.
引用
收藏
页码:888 / 893
页数:6
相关论文
共 50 条
  • [41] Prevalence and Risk Factors of Anemia in the MASHAD Cohort Study
    Tayefi, Maryam
    Ebrahimi, Mahmoud
    Soflaei, Sara Saffar
    Saljoughian, Sania
    Jaberi, Najmeh
    Rezaiyan, Majid Khadem
    Rahmani, Farzad
    Moohebati, Mohsen
    Esmaily, Habibollah
    Parizadeh, Seyed Mohammad Reza
    Heidari-Bakavoli, Ali Reza
    Safarian, Mohammad
    Nematy, Mohsen
    Azarpazhooh, Mahmoud Reza
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    ARCHIVES OF IRANIAN MEDICINE, 2023, 26 (06) : 310 - 315
  • [42] Risk factors for Panic Disorder in pregnancy: A cohort study
    Marchesi, Carlo
    Ampollini, Paolo
    Paraggio, Cecilia
    Giaracuni, Giovanna
    Ossola, Paolo
    De Panfilis, Chiara
    Tonna, Matteo
    Viviani, Daniela
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 156 : 134 - 138
  • [43] Perinatal factors and the risk of atopic dermatitis: A cohort study
    Parazzini, Fabio
    Cipriani, Sonia
    Zinetti, Cornelia
    Chatenoud, Liliane
    Frigerio, Luigi
    Amuso, Giuseppe
    Ciammella, Massimo
    Di Landro, Anna
    Naldi, Luigi
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2014, 25 (01) : 43 - 50
  • [44] Hormonal Factors and Risk of Psoriasis in Women: A Cohort Study
    Wu, Shaowei
    Cho, Eunyoung
    Li, Wen-Qing
    Grodstein, Francine
    Qureshi, Abrar A.
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (07) : 927 - 931
  • [45] Study Comparing Topical Ivermectin Versus Topical Permethrin in the Treatment of Scabies
    Saeed, Afshan
    Tariq, Shahan
    Iqbal, Majid
    Ismaeel, Hamza
    Mashhood, Asher
    Raza, Musarrat H.
    Hamid, Muhammad Ammar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [46] Risk factors for Staphylococcus aureus colonization in a general emergency department patient cohort - results of an observational cohort study
    Riedlinger, Dorothee
    Holert, Fabian
    Gastmeier, Petra
    Kola, Axel
    Slagman, Anna
    Moeckel, Martin
    BIOMARKERS, 2025, 30 (01) : 97 - 103
  • [47] Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil
    Amato, V. S.
    Tuon, F. F.
    Imamura, R.
    de Camargo, R. Abegao
    Duarte, M. I.
    Neto, V. A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (09) : 1026 - 1034
  • [48] Increased risk of pernicious anemia following scabies: a nationwide population-based matched-cohort study
    Liu, Jui-Ming
    Hsu, Ren-Jun
    Chang, Fung-Wei
    Chiu, Feng-Hsiang
    Yeh, Chia-Lun
    Huang, Chun-Fa
    Chang, Shu-Ting
    Lee, Hung-Chang
    Chi, Hsin
    Lin, Chien-Yu
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1205 - 1211
  • [49] Risk Factors for Heart Failure and Its Costs Among Children with Complex Congenital Heart Disease in a Medicaid Cohort
    Nandi, Deipanjan
    Rossano, Joseph W.
    Wang, Yinding
    Jerrell, Jeanette M.
    PEDIATRIC CARDIOLOGY, 2017, 38 (08) : 1672 - 1679
  • [50] Gender differences in risk factors for ischemic stroke: a longitudinal cohort study in East China
    Bai, Xinping
    Li, Zifeng
    Cai, Zhuo
    Yao, Mingren
    Chen, Lin
    Wang, Youmeng
    BMC NEUROLOGY, 2024, 24 (01)